The International Multicohort Consortium of Infectious Disease study group

AIDS Therapy Evaluation in the Netherlands Cohort (ATHENA): ​F Wit, Marc vd Valk, M Hillebregt, Stichting HIV Monitoring (SHM), Amsterdam, Netherlands

The Australian HIV Observational Database (AHOD): K Petoumenos, M Law, J Hutchinson, D Rupasinghe, W Min Han, UNSW Sydney, Sydney, Australia 

Austrian HIV Cohort Study (AHIVCOS): R Zangerle, H Appoyer, Medizinische Universität Innsbruck, Innsbruck, Austria

Brighton HIV cohort: J Vera,  A Clarke, B Broster, L Barbour, D Carney, L Greenland, R Coughlan, Lawson Unit, Royal Sussex County Hospital, University Hospitals Sussex NHS Foundation Trust, Brighton, United Kingdom

CHU Saint-Pierre: C Martin,  M Delforge, Centre de Recherche en Maladies Infectieuses a.s.b.l., Brussels, Belgium

Croatian HIV cohort:  J Begovac, University Hospital of Infectious Diseases, Zagreb, Croatia

EuroSIDA Cohort: J Kowalska, CHIP, Rigshospitalet, RegionH, Copenhagen, Denmark

Frankfurt HIV Cohort Study: C Stephan, M Bucht, Johann Wolfgang Goethe-University Hospital, Frankfurt, Germany

Georgian National AIDS Health Information System (AIDS HIS): A Abutidze, O Chokoshvili,  Infectious Diseases, AIDS and Clinical Immunology Research Center, Tbilisi, Georgia

Italian Cohort Naive Antiretrovirals (ICONA): A d’Arminio Monforte, A Rodanò, A Tavelli, I Fanti, Icona Foundation, Milan, Italy.

Modena HIV Cohort: C Mussini, V Borghi, M Menozzi, A Cervo, Università degli Studi di Modena, Modena, Italy

Nice HIV Cohort: C Pradier, E Fontas, K Dollet, C Caissotti, Université Côte d'Azur, Centre Hospitalier Universitaire de Nice, Department of Public Health, UR2CA, Nice, France.

PISCIS Cohort Study: J Casabona, JM Miro, Centre Estudis Epidemiologics de ITS i VIH de Catalunya (CEEISCAT), Badalona, Spain

Royal Free Hospital Cohort: M Johnson, C Smith, F Lampe, F Burns, C Chaloner, Royal Free Hospital, University College London, London, United Kingdom

San Raffaele Scientific Institute​: ​A Castagna, A Lazzarin, Università Vita-Salute San Raffaele, Milano, Italy

Swedish InfCare HIV Cohort: A Sönnerborg, C Carlander, P Nowak, J Vesterbacka, L Mattsson, D Carrick, K Stigsäter,  Department of Infectious Diseases, Karolinska University Hospital, and Division of Infectious Diseases, Department of Medicine Huddinge, Karolinska Institutet.
Sweden

Swiss HIV Cohort Study (SHCS): H Günthard, K Kusejko, H Bucher, University of Zurich, Zurich, Switzerland

University Hospital Bonn: JC Wasmuth, J Rockstroh, Bonn, Germany

University Hospital Cologne: C Lehmann, N Schulze, B Franke, Cologne, Germany


RESPOND Executive Committee 
L Ryom*, K Petoumenos*, J Rooney, M Dunbar, V Vannappagari, H Garges, L Young, R Campo, R Zangerle, C Mussini, C Martin, J Lundgren, H Günthard,  *Chairs

RESPOND Scientific Steering Committee
J Lundgren*, H Günthard*, L Ryom, M Law, D Raben, L Peters, J Rockstroh, O Kirk, D Podlekareva, A Volny-Anne, N Dedes, ED Williams, J Kowalska, A Abutidze, R Zangerle, K Petoumenos, F Wit, C Mertin, C Pradier, A D’Arminio Monforte, C Mussini, A Sönnerborg, C Lehmann, JC Wasmuth, F Burns, A Castagna, J Vera, J Begovac, J Rooney, D Thorpe, V Vannappagari, H Garges, L Young, R Campo *Chairs

Community Representatives:
Alain Volny-Anne, Nikos Dedes, Luis Mendão (European AIDS Treatment Group), Esther Dixon Williams (UK)

RESPOND Staff
Coordinating Centre Staff: JF Larsen, N Jaschinski, A Timiryasova, B Neesgaard, O Fursa, ML Jakobsen, M Gardizi, L Peters, L Ryom
Data Management Staff: B Pepa, L Ramesh Kumar, TW Elsing, O Valdenmaiier
Statistical Staff: L Greenberg, K Petoumenos, W Min Han, E Tusch, W Bannister
 

Funding

The International Cohort Consortium of Infectious Disease (RESPOND) is supported by The CHU St Pierre Brussels HIV Cohort, The Austrian HIV Cohort Study, The Australian HIV Observational Database, The AIDS Therapy Evaluation in the Netherlands National Observational HIV cohort, The EuroSIDA cohort, The Frankfurt HIV Cohort Study, The Georgian National AIDS Health Information System, The Nice HIV Cohort, The ICONA Foundation, The Modena HIV Cohort, The PISCIS Cohort Study, The Swiss HIV Cohort Study, The Swedish InfCare HIV Cohort, The Royal Free HIV Cohort Study, The San Raffaele Scientific Institute, The University Hospital Bonn HIV Cohort, The University of Cologne HIV Cohort, The Brighton HIV Cohort and The National Croatian HIV cohort. RESPOND is further financially supported by ViiV Healthcare, Merck Life Sciences, Gilead Sciences, Centre of Excellence for Health, Immunity and Infections (CHIP) and the AHOD cohort by grant No. GNT2023845 of the National Health and Medical Research Council, Australia.
 

Publication disclaimer:

The content of RESPOND publications is solely the responsibility of the authors and does not necessarily represent the official views of any of the listed institutions or funders